Comparison of Nasopharyngeal and Saliva Swab Nucleic Acid Amplification and Rapid Antigen Testing To Detect Omicron SARS-CoV-2 Variant of Concern: a Prospective Clinical Trial (OMICRON)

Comparison of Nasopharyngeal and Saliva Swab Nucleic Acid Amplification and Rapid Antigen Testing To Detect Omicron SARS-CoV-2 Variant of Concern: a Prospective Clinical Trial (OMICRON)

ABSTRACT In November 2021, the World Health Organization declared the Omicron variant (B.1.1.519) a variant of concern. Since then, worries have been expressed regarding the ability of usual diagnostic tests to detect the Omicron variant. In addition, some recently published data suggested that the...

Full description

Bibliographic Details
Main Authors: Antonios Kritikos, Giorgia Caruana, Catherine Lazor-Blanchet, Michael Currat, Jean-Daniel Chiche, Peter Vollenweider, Pierre-Alexandre Bart, Onya Opota, Gilbert Greub
Format: Article
Language:English
Published: American Society for Microbiology 2022-12-01
Series:Microbiology Spectrum
Subjects:
SARS-CoV-2 diagnosis
Omicron variant
RT-PCR
rapid antigen testing
nasopharyngeal swab
saliva swab
Online Access:https://journals.asm.org/doi/10.1128/spectrum.03923-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.03923-22

Similar Items